Trial Profile
Phase I Study to Evaluate the Safety of Zileuton (Zyflo) in Combination With Dasatinib (Sprycel) in Patients With Chronic Myelogenous Leukemia
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 04 Oct 2016
Price :
$35
*
At a glance
- Drugs Zileuton (Primary) ; Dasatinib
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions
- 29 Sep 2016 Status changed from recruiting to discontinued.
- 05 Feb 2014 New trial record